To this date, the full scope of the novel coronavirus outbreak remains a big guessing game. The CDC may come up with a solution soon, as serologic tests are being developed.
A vaccine for the novel coronavirus is still several months away, at least.
Finding some sort of other cure will not happen much sooner, if at all.
In the meantime, it is crucial to properly understand this pandemic and how it affects different countries.
For the CDC, that means developing new tests capable of providing more information regarding the novel coronavirus.
These serologic tests are slightly different from the ones used to testing for symptoms.
Under the new test, researchers can test anyone’s blood in regions where a lot of infections have been confirmed.
Based on that information, the CDC can determine if people are building up some sort of immunity to the novel coronavirus.
Two types of tests are currently being developed, but more time is needed.
Proper evaluation is currently underway to determine if this approach is useful and viable.
It is a very prominent development, and one that is direly needed.
As the number of infected patients keeps rising drastically, proactive countermeasures are more than welcome.
Justin Sun, CEO of TRON DAO, has just made one of his biggest announcements of…
$BNB has broken through a historic milestone. The token surged past $1,000, setting a new…
Decentralized finance (DeFi) has continued to disrupt traditional financial systems, offering permissionless access to lending,…
Solana’s app economy posted another breakout month. Total application revenues surged to $193.5 million in…
Sharps Technology (NASDAQ: STSS) is making a major move in the Solana ecosystem. The company,…
LivLive is redefining augmented reality (AR) gaming by turning real-world actions into measurable value for…